Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to BioMarck Pharmaceuticals in September, 2019 for $197,556.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41EY030832-01 | Phase I | 197,556 | September 30, 2019 | |||||||
A SBIR Phase II contract was awarded to BioMarck Pharmaceuticals in August, 2013 for $3,000,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HL073591-07 | Phase II | 3,000,000 | August 1, 2013 | |||||||
A SBIR Phase II contract was awarded to BioMarck Pharmaceuticals for $3,000,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HL073591-07 | Phase II | 3,000,000 | ||||||||
A SBIR Phase I contract was awarded to BioMarck Pharmaceuticals for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL073591-01 | Phase I | 100,000 | ||||||||
A SBIR Phase II contract was awarded to BioMarck Pharmaceuticals for $2,990,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HL073591-04 | Phase II | 2,990,000 |